rfhg_34894.1

Basic information about the TSS

---

TSS ID: rfhg_34894.1 Species: human Chr: chr2		Start: 173964285 End: 173964295 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3210852,EH38E2052745)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000418194.7:66 AY070137:66 GeneID: 6670 HGNC/MGI_ID: HGNC:11208 UniProt_ID: H0Y6K5 Q8WWU2 Q8WWU3 Nearer transcript ids and distances: LF347484:193 MA583061:193 ENST00000652005.2:216 AJ310752:-229 AJ430844:-229 ENST00000416195.1:-258 AY441958:-258 KJ904565:-259 HQ258632:-259 AB528284:-259 NM_001017371.5:405 M97191:458 LF347485:-482 MA583062:-482 X68560:497 view more...

Gene_name: Sp3 transcription factor Gene_symbol: SP3 Gene_synonyms: SPR-2 Gene_source: HGNC:11208

TATA-Box annotation

---

Distance to TSS:	-410
Nearest PromoterID:	NM_001017371
Entrez ID:	6670
Nearest Unigene:	Hs.531587
Nearest Refseq:	NM_003111
Nearest Ensembl:	ENSG00000172845
Gene Name:	Sp3 transcription factor
Gene Alias:	SPR2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.727273
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SP3 p2@SP3 p3@SP3 p4@SP3 p6@SP3 p8@SP3
Sample		p1@SP3	p2@SP3	p3@SP3	p4@SP3	p6@SP3	p8@SP3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.91	4.68	2.73	2.92	1.56	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.73	6.47	2.23	2.02	2.63	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.03	5.40	2.51	2.70	0.77	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.23	6.03	1.04	3.12	2.49	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.60	5.85	1.12	1.35	2.02	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.85	6.78	1.55	3.10	0.97	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	14.82	7.41	1.74	6.97	1.09	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.45	6.30	1.94	2.18	1.94	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.89	4.49	2.78	2.56	1.50	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.36	9.27	0.58	4.64	2.90	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	23.45	6.47	2.02	3.64	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	26.43	12.60	2.44	4.47	4.07	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.09	3.39	5.48	3.06	0.97	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.17	3.46	2.26	1.80	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.73	3.07	1.76	2.63	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.31	3.27	1.76	2.77	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.39	2.62	2.84	2.40	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	2.11	0.84	2.53	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.06	3.20	1.60	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.93	3.46	3.31	3.16	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.42	2.67	2.81	2.94	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.18	3.28	1.73	1.38	1.38	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.05	3.23	2.97	2.71	0.65	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.98	3.15	1.94	2.91	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.06	4.13	2.58	1.03	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	3.17	3.48	1.58	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	4.40	2.20	3.30	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.49	3.30	0.94	1.18	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.31	4.20	1.78	1.94	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.50	2.53	1.81	0.90	1.63	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	4.61	2.51	0.84	1.05	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.82	2.34	0.78	2.15	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.65	2.74	1.48	2.95	1.27	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.60	1.98	0.82	0.82	0.82	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.04	3.37	2.06	2.80	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.96	2.68	2.30	2.49	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.18	3.47	1.64	1.23	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.05	2.22	1.61	1.41	1.21	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	2.43	1.35	2.43	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.24	4.08	2.88	3.12	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.47	3.53	1.18	2.59	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.00	2.49	2.64	1.90	0.59	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.01	2.95	1.48	3.80	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.69	2.45	2.80	3.32	2.10	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.03	2.81	3.61	2.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.28	3.26	2.56	1.86	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.48	3.12	1.44	0.72	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.86	4.47	2.09	2.38	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.14	2.63	1.20	3.11	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.51	2.43	1.62	3.24	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.02	2.66	2.66	1.84	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	11.56	2.00	4.00	1.78	2.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.23	1.42	2.84	2.13	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.95	1.33	3.98	0.99	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	6.89	0.92	0.46	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.16	1.94	3.89	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.03	2.25	2.57	3.53	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.00	1.26	2.83	0.63	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.94	1.41	4.94	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.24	1.12	3.36	1.68	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	1.59	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.80	1.70	1.02	0.34	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.77	2.27	4.22	1.95	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.45	1.77	1.77	0.35	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	1.46	3.41	0.49	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.93	1.98	0.99	2.48	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	1.88	0.94	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.92	0.99	1.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.52	1.55	2.17	2.17	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.17	2.14	1.53	1.22	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	6.65	3.33	4.43	1.74	0.32	0.32
Adipocyte - breast, donor2	11327-117E4	7.06	3.69	2.89	0.64	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	8.02	3.69	5.73	0.76	0.51	0.38
Adipocyte - omental, donor2	11474-119C7	7.47	5.23	2.24	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	6.03	2.34	2.68	1.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	6.38	1.91	3.83	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	2.71	2.71	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	5.73	3.30	4.34	1.04	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	24.64	9.19	6.65	1.96	0.78	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	14.93	7.21	8.24	1.29	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	16.45	7.81	5.85	0.56	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	13.52	9.40	7.05	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	12.71	7.80	4.67	1.53	0.48	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	11.94	7.42	6.13	2.26	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	4.80	4.80	6.40	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	3.34	2.23	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.49	4.16	3.74	1.25	1.25	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	8.29	5.78	4.02	1.51	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	5.89	3.93	5.24	1.31	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	4.26	1.22	1.22	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	1.77	1.10	0.66	1.55	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	0.00	0.00	1.43	0.72	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	1.20	1.20	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.58	1.80	1.98	0.54	0.36	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	1.67	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.70	1.03	1.44	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	9.27	4.58	5.49	1.72	0.34	0.46
Anulus Pulposus Cell, donor2	11463-119B5	9.06	4.16	3.67	1.71	0.98	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.15	2.70	0.90	2.25	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4.78	2.17	0.00	1.30	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.99	0.90	2.09	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	1.26	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	1.32	0.66	2.64	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.20	0.97	2.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.40	1.94	1.94	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	3.56	2.38	1.78	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	3.77	1.88	0.00	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	3.63	1.45	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	3.76	3.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.94	2.64	3.46	1.15	0.33	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	4.09	0.00	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.98	1.81	2.87	0.90	0.90	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	2.14	4.29	1.07	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.29	2.65	4.16	0.94	0.76	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.22	3.21	4.54	0.80	1.07	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1.95	0.00	2.93	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.64	2.32	3.48	1.49	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	10.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.80	2.23	2.92	0.51	0.69	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	4.19	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	1.94	3.88	0.97	1.46	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.31	0.76	3.42	0.76	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	2.42	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	5.13	1.71	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.28	3.21	4.92	0.86	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.87	1.55	2.84	2.06	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	2.82	1.88	1.88	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.79	2.89	2.89	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	2.14	3.57	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	0.58	1.75	1.75	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.01	2.11	1.20	0.60	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	3.56	4.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.07	2.03	1.53	2.54	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	3.82	1.53	3.82	1.02	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	1.27	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	4.75	1.73	2.16	1.73	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	3.18	1.91	1.27	1.27	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	1.45	2.90	0.87	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	1.89	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.07	2.03	3.22	1.36	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	4.63	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.50	2.36	2.36	1.93	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	1.20	3.61	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	2.19	2.19	2.19	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	3.91	2.30	2.76	0.23	0.23	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	5.10	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.83	3.05	4.58	1.27	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.95	2.06	4.54	1.86	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.98	3.37	2.14	0.61	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	3.82	3.35	0.48	0.48	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.22	2.44	2.66	0.44	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	1.53	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	2.77	2.77	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.44	2.65	2.12	0.79	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	2.91	1.82	2.91	2.18	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	2.95	2.46	1.11	1.84	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	3.08	1.88	1.20	1.54	0.86	0.17
Astrocyte - cerebellum, donor3	11661-122F5	2.10	1.47	2.94	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	23.01	12.55	2.79	3.49	0.70	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	29.28	12.62	3.07	3.88	1.46	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	22.22	10.74	3.73	4.77	1.04	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	18.35	5.96	2.18	12.16	2.29	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.42	6.39	2.88	12.40	3.51	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	20.82	7.28	2.73	13.09	2.28	0.11
Basophils, donor1	12241-129G9	60.15	6.54	8.11	0.00	0.00	1.31
Basophils, donor2	12242-129H1	199.88	6.49	11.18	2.16	1.44	2.89
Basophils, donor3	12243-129H2	97.75	10.58	12.05	2.35	1.91	3.09
Bronchial Epithelial Cell, donor1	11511-119G8	0.86	0.22	0.65	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.46	0.46	1.83	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	5.02	2.51	1.88	0.63	1.26	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	3.54	1.66	1.04	1.25	0.62	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	5.53	1.15	0.92	1.61	0.92	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	10.08	3.96	0.72	1.98	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	25.25	10.92	2.78	4.95	2.58	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	22.82	7.22	1.63	10.71	1.40	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	58.52	5.44	6.72	2.88	0.32	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	10.34	10.34	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	84.53	7.89	14.65	1.13	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	107.65	9.47	14.11	2.23	2.04	1.48
CD14+ Monocytes, donor3	11381-118B4	102.52	9.44	18.44	1.76	0.66	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	32.55	11.32	15.57	3.11	2.26	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.12	13.65	15.16	3.03	1.90	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	8.22	12.49	1.64	3.29	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	82.10	21.39	17.63	5.93	7.66	4.48
CD14+ monocytes - mock treated, donor2	11873-125C1	66.08	12.67	12.97	5.13	4.83	3.32
CD14+ monocytes - mock treated, donor3	11883-125D2	67.99	15.63	12.32	3.79	3.55	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	49.88	12.55	7.53	4.69	4.18	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	41.40	15.18	4.42	4.14	1.93	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	47.35	11.90	6.20	2.73	3.47	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	34.46	9.59	3.92	4.11	5.29	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	28.13	8.01	3.38	3.38	1.78	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.13	8.92	3.92	1.74	0.87	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	62.28	14.75	7.49	2.81	4.21	2.58
CD14+ monocytes - treated with Candida, donor2	11878-125C6	57.56	8.98	5.81	1.06	2.11	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	45.48	14.42	9.98	2.22	4.44	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	70.51	15.62	11.75	5.80	6.54	4.46
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	50.49	11.77	6.59	4.39	2.39	2.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	58.50	9.58	9.58	2.08	0.62	2.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	66.58	18.07	11.44	4.35	2.75	3.20
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	47.73	10.41	7.01	1.13	1.58	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	54.56	10.91	6.98	0.87	4.36	3.06
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	38.73	11.84	6.46	5.65	5.11	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.29	11.17	5.76	3.49	4.19	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	42.92	12.62	6.31	3.79	5.05	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	35.46	14.33	4.41	4.59	2.94	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.01	10.92	2.82	2.11	3.87	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.88	14.04	2.63	1.75	2.63	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.28	12.03	5.75	4.01	3.31	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	38.28	6.69	5.20	3.35	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	54.75	11.42	7.11	2.37	1.08	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.03	9.83	7.37	3.28	5.73	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	24.80	5.56	3.25	1.62	0.46	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	28.77	7.89	3.48	3.48	0.46	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	60.59	8.72	18.96	2.18	1.53	4.58
CD14+CD16+ Monocytes, donor2	11801-124D1	65.83	9.70	18.02	2.77	1.62	4.16
CD14+CD16+ Monocytes, donor3	11912-125G4	58.27	6.50	22.53	2.38	1.08	4.12
CD14+CD16- Monocytes, donor1	11788-124B6	101.84	11.83	30.68	4.36	3.58	5.76
CD14+CD16- Monocytes, donor2	11799-124C8	91.86	11.70	25.32	3.32	2.62	5.41
CD14+CD16- Monocytes, donor3	11910-125G2	121.96	13.60	25.64	1.34	0.67	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	51.80	7.66	25.26	2.81	1.53	6.12
CD14-CD16+ Monocytes, donor2	11800-124C9	54.67	7.25	19.98	4.83	2.20	4.39
CD14-CD16+ Monocytes, donor3	11911-125G3	60.43	6.74	18.11	1.26	1.05	3.16
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	14.23	18.29	10.16	2.03	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	39.32	12.20	17.63	5.42	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	39.35	6.21	22.78	12.43	2.07	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	35.71	14.39	17.06	14.39	1.60	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	49.85	19.30	21.98	5.36	2.68	4.82
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	32.99	12.63	22.46	4.91	0.70	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.06	15.69	25.88	10.20	2.35	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	10.55	22.41	11.86	2.64	3.95
CD19+ B Cells, donor1	11544-120B5	166.85	13.97	12.33	13.97	4.11	3.29
CD19+ B Cells, donor2	11624-122B4	155.97	16.68	19.59	10.16	5.80	2.18
CD19+ B Cells, donor3	11705-123B4	160.53	15.65	18.17	8.08	2.52	4.54
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	17.78	22.22	2.02	8.89	4.04	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	17.98	22.37	3.60	6.79	3.60	1.60
CD34+ Progenitors, donor1	11545-120B6	99.40	2.01	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	107.31	4.49	7.30	0.56	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	27.81	3.38	8.64	6.76	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	39.01	6.99	5.19	1.58	1.58	0.45
CD4+ T Cells, donor1	11225-116C1	233.16	14.64	16.78	7.14	2.50	1.79
CD4+ T Cells, donor2	11306-117C1	198.41	12.25	11.02	9.80	4.29	4.29
CD4+ T Cells, donor3	11382-118B5	201.91	17.08	10.67	6.10	3.35	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	55.90	9.70	5.10	6.38	3.32	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	69.85	11.90	6.51	11.01	3.14	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	61.52	10.92	6.90	11.21	3.45	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	136.54	10.90	7.59	5.69	3.32	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	101.13	12.64	11.24	9.83	3.51	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	19.78	6.59	13.18	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	51.45	5.93	3.90	6.21	3.32	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	51.01	8.98	4.91	8.98	3.39	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	50.62	8.54	5.32	6.77	2.74	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	92.35	6.28	9.41	9.86	2.24	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	87.35	9.78	5.94	6.99	4.19	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	113.52	7.92	6.60	4.40	2.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	70.41	7.59	7.17	2.53	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	54.85	7.27	6.03	7.90	3.12	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	52.12	9.36	8.02	6.01	2.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	127.27	22.30	13.05	9.52	5.44	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	153.82	16.61	10.18	12.33	5.90	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	114.77	14.35	16.14	8.97	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	70.28	9.46	5.38	8.53	3.34	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	55.24	7.15	4.33	6.93	3.25	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	62.84	10.51	7.78	7.36	1.89	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	94.04	11.12	9.10	4.04	3.54	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	98.78	6.50	8.23	5.63	3.03	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	121.59	4.36	5.67	3.92	1.74	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	92.05	11.88	17.82	7.92	1.48	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	60.01	13.85	12.92	4.62	1.85	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	86.54	6.98	13.96	4.19	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	93.60	14.12	14.95	5.26	3.05	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	96.93	12.51	15.21	8.59	1.96	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	110.88	16.94	20.02	9.24	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	83.08	12.89	10.03	8.24	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	94.18	8.31	8.31	2.77	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	193.49	7.20	14.73	3.60	3.27	1.64
CD8+ T Cells, donor2	11307-117C2	210.62	7.13	15.77	3.38	1.88	3.38
CD8+ T Cells, donor3	11383-118B6	225.98	9.34	19.44	7.32	3.79	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.42	2.52	0.92	3.21	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.27	2.40	0.72	5.27	1.20	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.92	3.01	0.55	4.92	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.10	4.50	0.90	3.90	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.08	2.16	0.72	4.80	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.91	3.41	1.36	3.87	1.14	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.08	2.82	1.52	3.48	1.30	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.74	3.16	1.32	2.90	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.10	2.81	0.94	5.16	1.64	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.75	3.92	1.81	4.53	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	3.20	2.03	7.84	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.39	2.13	1.07	5.06	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	4.82	3.06	1.75	3.50	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.55	4.10	2.28	4.55	0.00	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	2.98	1.49	4.48	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.32	2.88	2.16	3.96	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.89	3.16	0.58	3.74	1.15	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.42	2.36	0.94	5.19	2.12	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.39	3.49	1.90	6.34	1.58	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.38	3.38	1.54	4.00	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.49	2.89	1.92	3.53	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.35	3.06	0.76	4.59	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.52	1.58	1.18	5.91	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	1.51	2.27	5.29	2.27	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	6.42	4.82	11.24	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	19.58	11.89	2.10	10.49	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	12.02	7.01	3.01	15.03	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	20.11	12.79	1.83	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.40	1.98	5.43	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	6.63	3.05	1.37	1.16	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	9.01	4.85	1.04	1.39	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	3.20	3.20	3.20	0.71	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.65	4.32	4.44	1.48	1.14	0.23
Chondrocyte - re diff, donor2	11339-117F7	7.16	2.69	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	6.47	4.45	4.04	0.00	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	18.02	7.23	2.98	3.67	0.92	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	10.47	5.77	1.92	2.78	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	11.06	5.84	1.68	2.21	0.80	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	8.89	6.33	6.05	6.88	1.56	0.73
Corneal Epithelial Cells, donor1	11526-119I5	1.98	0.44	0.88	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	0.00	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	3.32	1.02	0.77	1.02	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.73	3.14	4.13	3.14	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.41	2.21	7.25	1.26	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.56	2.81	3.46	2.27	0.97	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	156.47	13.67	36.90	3.07	3.07	7.17
Dendritic Cells - plasmacytoid, donor2	11309-117C4	126.00	13.06	35.25	3.26	1.31	6.53
Dendritic Cells - plasmacytoid, donor3	11385-118B8	216.81	12.10	29.04	1.45	0.48	3.39
Endothelial Cells - Aortic, donor0	11207-116A1	4.50	2.00	2.17	0.50	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	1.17	1.76	1.76	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.39	1.98	1.70	0.85	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	1.97	1.97	1.18	0.39	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	2.62	1.16	2.33	1.16	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.00	3.06	2.12	1.65	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	3.86	1.75	1.58	1.23	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.76	2.88	1.11	2.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	4.56	3.35	1.83	2.74	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	4.23	1.41	2.82	3.38	1.69	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	2.08	1.78	4.46	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	2.60	2.08	2.08	1.04	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	0.85	1.42	3.54	1.42	0.57	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	7.20	5.20	1.60	2.40	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	1.57	2.10	2.10	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.52	3.60	3.73	3.60	0.87	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	13.90	6.30	1.96	2.39	1.09	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.99	5.13	2.69	2.69	1.22	0.12
Endothelial Cells - Vein, donor1	11267-116G7	6.83	2.28	9.10	2.28	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2.10	3.49	1.40	1.40	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	7.85	2.67	2.67	1.57	0.00	0.16
Eosinophils, donor1	12244-129H3	152.47	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	427.42	33.01	41.26	1.65	3.30	3.30
Eosinophils, donor3	12246-129H5	235.41	17.83	35.67	3.57	3.57	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	0.24	0.49	0.73	0.49	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	4.11	6.98	0.82	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.18	0.77	0.88	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.32	2.49	2.06	0.43	0.43	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.28	4.61	2.06	1.33	0.12	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.82	2.05	3.68	0.82	0.55	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	5.06	3.59	2.85	0.63	0.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.38	3.43	5.01	2.11	1.05	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	11.96	3.99	1.66	1.99	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	7.26	0.91	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	5.31	0.76	3.03	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.15	1.10	1.10	0.79	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	13.94	4.85	3.94	0.61	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	9.52	4.31	4.06	2.16	0.63	0.13
Fibroblast - Cardiac, donor6	11460-119B2	11.82	5.15	3.94	0.91	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	5.09	2.81	1.74	0.27	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.77	4.75	1.73	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	11.72	8.79	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	3.46	1.85	1.38	0.46	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.94	10.85	7.63	1.53	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	7.75	2.35	3.76	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	2.36	0.94	1.89	0.94	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	7.74	4.47	4.11	1.09	0.24	0.73
Fibroblast - Dermal, donor4	11450-119A1	17.86	6.10	2.37	4.63	1.47	0.34
Fibroblast - Dermal, donor5	11454-119A5	20.24	9.07	2.09	3.66	1.40	0.17
Fibroblast - Dermal, donor6	11458-119A9	20.30	7.47	3.09	4.39	1.46	0.16
Fibroblast - Gingival, donor1	11237-116D4	15.41	4.37	3.12	1.46	0.21	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.00	6.55	7.86	1.57	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	14.76	5.80	3.69	2.24	0.66	0.26
Fibroblast - Gingival, donor3	11394-118C8	21.27	8.41	9.77	1.35	0.39	1.35
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	6.23	4.16	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.22	4.76	5.99	0.53	0.88	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.45	7.95	6.39	1.56	1.71	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.83	5.41	5.27	2.03	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.82	10.59	10.94	1.41	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.50	5.56	5.70	2.49	1.02	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.91	6.41	5.59	2.45	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.10	7.90	3.62	2.63	0.77	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.67	6.60	13.50	3.37	1.47	1.17
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	5.44	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	2.98	2.98	2.98	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	5.06	5.70	2.74	1.06	0.63	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	5.83	0.83	4.17	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	2.80	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	0.00	1.40	1.40	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	4.87	2.44	4.06	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	17.07	6.79	5.24	3.88	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.06	7.89	3.79	6.83	1.97	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	17.75	6.43	3.37	1.53	1.53	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.50	4.58	3.82	0.38	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.45	4.59	3.24	1.62	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.44	5.33	4.64	1.04	0.70	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.62	3.76	1.88	0.88	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3.45	2.03	2.24	0.61	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.01	0.00	2.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.70	5.54	3.56	0.79	0.00	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	16.47	6.35	2.98	4.37	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	7.64	4.80	10.30	0.71	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	10.05	5.12	4.73	1.18	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.83	3.91	3.91	1.81	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.28	6.59	3.78	1.30	0.32	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.38	5.06	6.58	2.53	1.77	0.76
Fibroblast - skin normal, donor1	11553-120C5	9.52	3.77	6.23	1.31	0.49	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	21.05	6.82	5.01	2.61	2.81	0.60
Fibroblast - skin normal, donor2	11561-120D4	12.76	4.72	5.22	0.70	0.50	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	18.74	6.35	8.76	5.44	2.12	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.35	6.13	7.54	1.74	0.50	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.21	4.44	9.74	0.34	0.68	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.17	5.25	6.57	3.28	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.57	3.73	2.66	1.28	0.43	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	7.93	3.88	3.88	1.52	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.90	2.20	0.78	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	30.50	1.74	1.74	3.49	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.11	3.64	2.77	0.87	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.53	2.86	2.60	1.56	0.52	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.20	3.58	1.79	1.79	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	3.06	3.06	7.66	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.87	6.38	1.28	5.10	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	20.82	7.42	0.86	5.99	0.86	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	38.61	11.86	7.17	11.58	1.38	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.08	11.42	6.16	4.34	1.37	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	27.14	8.32	2.58	10.90	1.19	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	38.06	10.31	5.82	14.80	2.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	39.79	12.72	8.48	6.52	0.98	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.00	10.61	1.33	8.40	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.25	9.47	2.40	6.78	2.97	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.96	10.10	2.46	6.28	1.60	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.46	9.67	2.15	7.79	2.15	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	15.36	5.70	1.12	5.08	1.36	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.12	7.61	1.52	5.95	1.25	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.57	5.08	1.02	7.52	2.03	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.60	6.62	1.83	3.19	1.14	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.57	7.35	2.24	3.99	1.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.49	6.34	2.40	5.25	1.31	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.89	6.50	2.66	3.84	1.18	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.12	6.36	2.38	3.18	1.91	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.75	6.03	1.56	5.36	2.23	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.11	6.86	4.23	6.86	2.02	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.59	7.12	2.71	5.09	1.87	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.61	9.58	2.66	6.21	1.95	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.19	6.04	3.54	7.80	2.60	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.39	5.81	3.76	4.95	1.20	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	17.04	5.31	2.10	4.65	2.10	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.13	6.82	3.41	4.83	2.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.70	7.15	3.27	5.51	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.24	5.57	1.86	5.98	1.24	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.37	6.00	3.00	4.73	1.50	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	11.17	4.67	2.84	5.67	1.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.12	3.97	2.20	6.61	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	13.04	4.55	2.34	3.69	1.84	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.02	3.89	2.92	5.02	1.46	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	14.75	1.92	3.53	4.81	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.61	5.97	3.41	4.64	1.14	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	8.38	4.43	2.53	4.59	0.95	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	12.47	3.95	3.95	3.95	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.14	4.08	2.93	3.55	1.46	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	11.64	2.20	1.76	2.63	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	8.42	5.05	1.68	1.96	1.96	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	10.83	3.80	3.33	2.50	1.11	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	11.50	3.21	2.94	3.74	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.32	3.37	2.91	5.20	2.30	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.20	2.98	2.85	0.91	0.91	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	10.03	3.25	2.98	3.52	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.72	3.69	3.87	1.47	1.66	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	11.40	4.39	3.95	1.32	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	17.85	2.98	2.98	1.98	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.87	3.17	3.83	1.71	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.32	4.64	3.03	2.02	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	13.98	7.88	3.05	2.03	1.02	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.12	12.94	1.39	7.56	2.99	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	14.95	8.32	0.62	7.09	1.39	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	21.69	14.12	2.86	12.07	2.05	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	12.83	1.56	2.50	5.01	1.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.87	3.67	1.70	3.96	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	20.29	6.00	4.61	12.91	2.77	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	7.42	9.90	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.43	9.28	5.03	5.42	1.16	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	4.81	1.60	3.21	4.81	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	26.08	8.69	8.69	0.00	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.78	8.14	5.53	4.56	2.28	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	15.24	12.77	4.53	7.41	5.35	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	3.33	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	21.25	10.07	5.03	5.03	2.80	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.26	7.84	6.21	3.92	0.65	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	21.81	3.36	5.03	5.03	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	20.99	8.27	5.09	5.09	1.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.68	5.43	3.06	11.21	3.06	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	6.26	4.18	2.09	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.34	10.31	3.44	10.31	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.14	6.22	1.78	3.26	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	5.08	1.69	8.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.67	8.28	6.63	6.63	1.66	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	17.49	7.36	6.67	4.60	0.69	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.68	11.53	3.84	7.30	3.08	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.71	4.24	5.54	4.24	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.73	6.02	5.35	7.36	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.88	8.86	4.24	6.93	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	21.23	15.06	11.30	1.37	1.37	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	19.88	7.45	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	6.13	7.08	5.19	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	27.76	15.09	7.85	7.24	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	23.91	11.70	4.58	7.63	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	20.74	9.97	5.18	5.58	1.60	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	21.21	13.81	5.92	9.87	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	28.33	15.35	5.90	10.62	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	24.50	9.34	6.42	3.50	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.89	9.22	7.02	5.27	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	9.32	5.09	4.24	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	5.97	1.19	2.39	2.39	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.47	5.82	6.31	2.43	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	6.85	6.85	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	5.41	4.57	2.08	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	2.25	9.00	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.76	2.22	3.17	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.43	2.09	1.25	0.42	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	11.02	4.29	0.58	2.79	1.28	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.80	2.19	1.18	1.86	1.18	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.69	2.50	0.68	4.10	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.24	4.70	0.66	3.39	1.09	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.96	2.79	0.86	2.58	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.67	4.52	1.08	1.51	2.15	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.97	3.36	0.50	1.99	1.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.66	1.20	1.20	1.37	0.51	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.37	2.24	0.32	2.24	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.24	2.80	0.56	1.68	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	0.87	1.73	1.73	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	2.64	0.00	5.29	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1.06	2.12	4.59	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	1.45	5.09	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.69	2.97	1.92	1.05	0.87	0.00
Hepatocyte, donor1	11523-119I2	15.74	4.84	13.32	2.42	2.42	2.42
Hepatocyte, donor2	11603-120I1	15.08	4.31	22.62	5.39	1.08	3.23
Hepatocyte, donor3	11684-122I1	7.36	6.75	4.91	4.91	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.30	5.22	11.10	8.48	3.26	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.34	12.23	5.24	3.32	2.27	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	6.45	2.20	0.55	1.92	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	9.55	12.74	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	20.03	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	27.08	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	9.69	9.69	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	7.51	7.51	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	11.87	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	17.94	17.94	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	18.28	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	3.25	17.87	12.99	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	6.67	10.00	5.00	5.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	7.26	7.26	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	2.65	18.53	7.94	2.65	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	1.11	12.20	7.76	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	10.48	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	5.67	11.97	7.56	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00	17.01	9.28	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.88	0.00	14.21	6.46	1.94	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	4.83	11.27	8.05	6.44	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	23.90	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	3.26	21.19	8.15	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.68	1.26	12.17	5.88	1.26	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.82	2.41	16.07	6.43	1.61	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	0.92	2.77	6.46	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	60.32	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.78	0.47	6.14	4.25	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	1.81	3.63	8.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	44.23	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	2.15	8.61	5.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	0.00	6.35	7.62	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	3.19	14.67	7.65	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	14.58	10.94	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1.43	1.43	12.85	3.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	6.64	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.40	0.62	4.94	7.10	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	3.51	5.27	14.05	3.51	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	6.29	3.14	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	2.09	8.34	9.74	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	2.21	4.43	30.98	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	0.00	9.73	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	6.10	11.34	7.85	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	2.25	4.50	13.50	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	3.48	10.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	3.20	9.60	9.60	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	4.16	6.93	20.78	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	8.55	14.25	14.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	0.92	11.05	16.57	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	9.08	6.05	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	12.42	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	2.11	6.34	13.75	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.40	1.96	1.55	0.73	0.65	0.16
Keratinocyte - epidermal, donor2	11349-117G8	2.93	0.00	0.59	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	12.02	3.50	1.61	2.75	0.66	0.19
Keratinocyte - oral, donor1	11251-116E9	17.25	4.65	2.84	3.29	1.25	0.11
Keratocytes, donor1	11527-119I6	3.44	1.03	2.06	1.38	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	1.17	2.34	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	8.50	5.53	3.36	1.98	0.79	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	13.19	15.39	0.00	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	6.47	1.08	1.08	3.24	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	11.99	5.77	3.00	4.50	0.58	0.23
Lens Epithelial Cells, donor3	11690-122I7	7.27	2.83	1.82	2.52	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2.85	2.02	1.19	0.59	0.59	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1.67	1.40	0.84	0.56	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.35	2.99	3.15	1.89	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1.61	1.08	2.69	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.47	0.32	2.21	0.32	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.73	0.65	1.19	0.32	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	2.05	3.28	1.23	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.01	0.25	0.51	0.00	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2.11	0.99	2.25	1.41	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.96	1.19	0.79	1.19	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.30	0.97	1.74	0.58	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	0.56	0.56	2.78	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	2.09	4.88	1.74	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.62	2.15	1.67	0.95	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1.10	1.10	0.82	0.41	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.16	2.46	1.85	2.16	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.87	1.25	1.87	1.25	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.01	1.46	1.83	0.73	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1.65	1.97	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	0.88	0.88	0.29	0.88	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	0.50	0.25	2.49	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.33	0.97	2.91	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	1.89	1.35	1.08	1.62	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1.67	0.76	1.06	1.06	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	0.52	0.52	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	4.82	3.35	1.47	1.68	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1.50	0.90	1.35	0.30	1.20	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	3.44	0.69	1.38	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.57	1.88	2.63	1.32	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.38	0.64	1.91	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.36	1.45	1.94	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	1.65	0.33	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	0.87	0.62	1.36	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	4.81	2.96	2.22	1.48	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.95	2.72	1.98	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.65	0.41	1.24	0.41	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	4.50	0.64	0.32	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.52	3.04	2.43	1.22	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	2.94	2.24	1.82	0.70	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	3.20	2.49	1.78	1.42	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.94	0.48	2.42	1.94	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	0.47	0.47	1.24	0.47	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.58	1.07	1.79	0.72	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.96	1.96	0.65	0.98	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.94	0.00	1.88	0.47	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	4.70	1.61	1.24	0.37	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.28	1.02	1.28	1.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	0.90	0.00	1.19	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	4.53	13.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	3.07	11.51	3.84	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	1.48	6.68	1.48	0.00	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.12	4.23	9.73	1.27	2.12	5.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	4.22	9.85	1.41	2.81	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	4.67	9.34	0.93	0.93	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	3.61	8.24	0.00	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	2.38	10.71	1.19	3.57	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.57	2.04	11.76	2.04	0.68	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.87	3.49	5.82	1.16	1.45	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	2.70	7.20	3.60	2.70	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.66	3.39	11.38	2.17	0.54	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.84	3.59	6.16	0.51	2.05	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.88	3.88	4.23	2.47	1.76	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	3.33	4.66	0.67	0.00	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.87	4.08	10.19	3.06	1.02	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	18.41	5.34	4.27	1.87	1.60	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	16.82	4.35	5.10	1.51	1.32	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.73	4.91	17.79	3.07	3.07	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	6.52	6.52	4.08	3.26	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	19.16	5.00	6.25	1.67	1.46	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.69	3.92	3.64	2.52	0.84	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	21.64	5.15	14.42	1.03	1.03	7.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.90	4.64	6.39	1.45	0.58	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.03	3.29	5.38	2.09	1.49	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	3.32	3.87	1.66	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.38	4.95	12.73	2.83	1.77	3.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.12	4.43	10.33	1.11	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	4.61	9.21	2.30	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.20	3.07	12.66	0.77	1.54	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.29	1.70	7.93	3.40	0.57	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	1.64	12.31	2.46	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.72	3.16	14.46	0.90	0.45	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	5.03	17.24	0.00	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	2.24	11.20	4.48	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	12.63	3.72	8.92	4.09	1.86	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.80	2.58	11.63	0.00	1.29	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	4.28	6.85	0.86	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.66	2.00	9.33	3.00	0.67	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.70	1.81	7.24	2.41	0.60	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	3.55	9.95	3.55	3.55	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.34	2.75	14.78	2.75	0.69	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.81	3.76	10.73	0.54	1.61	4.83
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.79	4.04	9.43	3.37	1.35	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.67	2.22	12.59	1.48	4.44	4.07
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	5.81	15.12	1.16	0.00	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	8.46	7.40	8.46	3.17	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.21	3.20	11.60	2.00	1.60	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	3.63	17.44	0.00	1.45	7.27
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	3.07	16.10	2.30	2.30	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	4.93	13.32	2.96	1.48	5.92
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	5.65	13.17	0.00	0.94	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	2.51	16.59	3.52	1.01	5.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.67	2.70	13.97	2.25	0.90	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	6.88	1.72	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.81	4.45	14.25	3.56	1.78	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	3.13	7.82	2.74	3.52	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.83	1.98	7.92	1.32	3.96	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.68	2.59	6.75	2.08	2.08	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.38	7.00	12.69	2.19	0.44	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	19.57	3.35	9.50	2.80	1.68	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.57	6.62	7.95	1.77	0.88	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.96	3.09	10.03	1.93	0.77	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.72	1.52	7.60	2.03	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.86	3.84	8.17	0.96	2.88	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.11	5.57	7.16	1.99	1.99	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	4.25	9.11	3.04	3.65	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	3.46	7.61	3.46	4.15	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.62	3.42	7.60	2.66	2.28	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.91	6.20	10.84	1.55	2.07	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	4.23	4.84	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.45	3.80	8.56	1.27	1.27	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.59	2.67	5.33	2.67	1.60	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.92	2.87	10.92	4.02	0.57	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.91	6.17	13.37	5.66	2.57	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	5.66	5.66	1.41	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	4.54	6.81	2.84	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.56	3.74	7.49	2.08	2.50	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	0.78	6.26	0.78	3.13	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.36	4.59	5.85	2.92	2.51	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	3.72	10.22	0.46	2.79	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	13.38	3.35	8.70	2.01	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.18	2.14	4.81	2.67	1.07	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.53	7.27	9.70	1.62	0.40	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	3.67	8.26	0.92	1.84	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	18.67	3.56	9.78	3.56	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	3.42	6.27	1.71	3.42	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	1.53	13.04	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.59	2.74	3.83	1.09	1.64	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.14	4.45	6.24	4.45	0.45	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	14.30	2.34	10.14	0.52	1.04	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	4.64	6.63	3.32	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08	18.71	2.08	4.16	4.16
Macrophage - monocyte derived, donor1	11232-116C8	17.32	5.70	10.48	1.14	0.91	1.82
Macrophage - monocyte derived, donor2	11313-117C8	6.42	2.39	3.12	2.20	0.92	0.18
Macrophage - monocyte derived, donor3	11389-118C3	12.71	3.93	5.37	2.23	0.79	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	2.12	1.06	1.06	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	10.93	3.01	2.06	0.48	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	8.62	2.50	2.08	0.14	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	28.10	4.88	2.09	1.69	0.50	0.10
Mammary Epithelial Cell, donor2	11350-117G9	18.53	4.92	1.16	2.03	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	3.49	1.50	1.50	0.50	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	107.79	0.00	2.71	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	28.87	3.46	4.76	3.57	1.51	0.43
Mast cell, donor2	11565-120D8	54.38	21.69	17.53	3.57	1.49	1.19
Mast cell, donor3	11566-120D9	64.39	27.24	31.29	3.38	1.80	1.80
Mast cell, donor4	11567-120E1	55.49	21.10	20.03	1.95	1.24	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	22.18	3.99	3.22	3.11	0.78	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	23.35	1.17	5.25	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	27.99	5.16	5.39	2.75	1.15	0.11
Mast cell, expanded, donor8	11941-126A6	28.79	4.85	14.23	2.01	0.50	0.50
Melanocyte - dark, donor1	11502-119F8	6.67	2.59	1.79	2.09	0.99	0.10
Melanocyte - dark, donor2	11582-120F7	8.65	3.81	5.54	0.69	1.04	0.35
Melanocyte - dark, donor3	11663-122F7	13.47	5.65	2.97	4.13	0.87	0.58
Melanocyte - light, donor1	11274-116H5	4.00	1.18	1.88	1.18	0.71	0.00
Melanocyte - light, donor2	11351-117H1	0.68	3.41	2.73	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	3.47	2.60	3.47	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	10.10	5.31	2.19	1.87	1.25	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	8.07	1.34	2.15	4.84	1.34	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	9.37	4.82	3.75	1.34	0.80	0.27
Meningeal Cells, donor1	11493-119E8	5.33	2.61	1.24	1.49	0.87	0.00
Meningeal Cells, donor2	11573-120E7	7.04	2.64	1.32	2.20	0.44	0.00
Meningeal Cells, donor3	11654-122E7	16.95	5.87	1.14	3.59	1.22	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.69	3.14	2.57	2.00	1.71	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.23	2.82	3.42	1.11	0.50	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	3.94	10.51	0.00	0.00	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	0.00	3.92	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	6.46	1.44	2.87	2.87	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	5.51	2.12	3.81	0.64	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.53	1.51	3.52	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.40	1.32	1.98	1.54	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	0.00	1.46	2.19	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.46	1.84	1.43	1.23	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.83	5.12	3.60	0.83	0.28	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.86	1.12	3.35	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.92	3.42	3.16	0.26	0.39	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	0.00	4.15	0.00	0.00	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	4.67	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	1.92	2.56	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.05	5.67	1.42	1.42	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	8.13	4.07	0.63	0.94	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	3.63	2.90	3.63	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	5.57	3.98	4.51	0.53	0.27	1.06
Mesothelial Cells, donor2	12156-128G5	4.00	1.50	6.51	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	4.70	2.38	4.99	0.51	0.43	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	6.75	8.10	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.33	2.96	8.13	1.48	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.66	2.65	6.48	4.71	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	17.29	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.23	2.17	3.10	3.41	0.31	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.64	3.53	3.53	2.49	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	12.26	2.50	4.25	3.25	2.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.45	3.72	6.05	2.79	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.33	3.86	3.66	1.63	1.83	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.15	1.98	5.15	1.98	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	2.65	3.54	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	5.70	2.28	3.04	2.28	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	2.63	2.63	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.52	1.27	2.97	0.64	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	0.92	1.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.47	1.49	1.19	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.76	1.25	1.51	0.75	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.90	0.95	2.14	1.66	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	1.11	1.66	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.69	0.69	2.53	1.15	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.26	1.68	2.73	1.26	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.02	0.82	1.83	0.61	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	1.29	2.57	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.00	1.56	1.33	1.11	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.75	0.66	0.88	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	0.51	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.27	0.54	0.27	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.47	1.18	1.18	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	0.96	0.96	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.60	2.00	0.80	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	1.00	0.00	3.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.07	2.19	1.75	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	4.41	3.31	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.64	1.92	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.73	0.99	2.23	2.23	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	2.21	4.42	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	4.44	4.44	0.68	0.34	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	0.88	0.88	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.62	3.91	0.71	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.09	1.40	1.40	1.40	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	2.08	0.83	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.91	3.50	2.33	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.13	3.02	1.81	1.51	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	1.25	1.25	0.83	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	21.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	2.77	0.00	2.77	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	3.41	3.98	1.14	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.94	2.76	0.97	0.55	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.00	2.33	2.07	1.04	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.43	2.14	4.72	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	1.27	3.18	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.47	1.87	1.87	0.80	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.18	2.99	2.99	2.99	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.24	2.26	2.40	2.12	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	2.23	1.59	1.27	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	8.85	3.76	2.21	1.33	1.11	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.83	1.52	3.41	1.14	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.08	0.00	1.99	0.00	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.85	2.95	3.69	1.23	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	1.96	9.12	1.30	1.30	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.41	2.94	3.23	1.47	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.67	3.17	4.61	2.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.54	3.30	6.59	2.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.96	4.76	7.15	2.98	0.60	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	15.07	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	8.91	5.35	1.78	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	3.61	8.54	1.31	1.31	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	3.16	1.05	3.16	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.28	6.33	19.77	1.38	0.79	4.74
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	3.73	7.45	0.00	0.00	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.40	4.51	10.14	0.75	1.50	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.46	3.20	7.19	0.80	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.04	3.73	9.39	0.23	0.11	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	1.47	5.16	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.69	3.66	8.06	1.10	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	6.22	7.78	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.88	2.67	4.28	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	0.00	4.04	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	3.79	2.11	2.11	0.84	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	2.72	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	3.02	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	11.42	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	3.26	22.84	0.00	0.00	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	50.20	0.00	0.00	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.68	2.59	3.88	1.08	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.14	1.05	4.18	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	0.67	2.67	3.34	2.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.26	3.76	1.25	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.35	3.23	0.76	0.57	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	4.79	0.00	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.68	2.04	0.00	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.30	1.26	3.77	1.26	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.78	0.70	0.70	0.70	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	3.24	2.43	1.62	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.35	4.84	4.41	1.47	1.26	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.44	4.47	3.97	2.48	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	13.53	2.98	3.52	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.84	1.81	2.27	0.91	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.31	1.31	3.43	0.98	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.66	4.37	3.83	1.82	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	2.65	4.77	1.06	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	1.80	1.80	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.19	2.63	1.97	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.72	2.76	2.93	0.98	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.17	3.70	6.17	1.59	0.53	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	4.22	2.11	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	3.22	2.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.57	3.86	2.89	1.93	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.59	1.03	0.69	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.80	4.90	3.12	0.22	1.11	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	4.23	2.54	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.73	2.37	4.51	0.47	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	5.15	3.43	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.33	3.00	2.33	2.00	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	2.71	4.06	2.71	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.97	2.38	2.38	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	5.57	6.50	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	11.35	4.16	2.27	0.76	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	2.61	2.28	2.61	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	3.05	3.92	2.61	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	6.33	3.17	2.71	1.81	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	1.76	0.88	3.53	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	6.65	1.99	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	6.45	6.45	2.48	1.98	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.51	0.77	3.45	0.77	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	4.54	2.42	1.21	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5.75	3.32	3.98	1.99	0.88	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	6.10	3.39	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	4.27	6.10	2.44	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.24	2.83	1.89	1.57	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.66	2.12	2.72	1.21	0.61	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	2.37	3.16	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	5.67	4.53	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.70	2.61	1.12	0.50	0.12	0.12
Myoblast, donor2	11322-117D8	12.85	5.75	4.60	0.77	0.19	0.58
Myoblast, donor3	11398-118D3	10.76	6.73	2.35	1.35	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	34.73	5.69	3.94	5.40	2.63	0.00
Natural Killer Cells, donor1	11230-116C6	210.65	8.30	13.84	2.15	3.69	0.62
Natural Killer Cells, donor2	11311-117C6	205.36	7.54	12.36	5.43	2.11	3.02
Natural Killer Cells, donor3	11387-118C1	193.62	9.57	14.72	4.42	3.13	3.31
Neural stem cells, donor1	11275-116H6	36.29	10.53	7.62	6.17	1.81	1.45
Neural stem cells, donor2	11352-117H2	30.81	21.18	3.85	5.78	9.63	0.00
Neurons, donor1	11494-119E9	20.48	9.10	11.38	7.97	10.24	1.14
Neurons, donor2	11574-120E8	10.35	12.77	3.30	7.71	1.98	0.66
Neurons, donor3	11655-122E8	23.84	9.87	1.64	15.62	4.93	0.82
Neutrophils, donor1	11233-116C9	306.24	19.49	41.76	5.57	11.14	5.57
Neutrophils, donor2	11314-117C9	205.82	40.58	26.09	2.90	17.39	0.00
Neutrophils, donor3	11390-118C4	513.11	33.60	47.03	15.88	9.77	6.11
Nucleus Pulposus Cell, donor1	11252-116F1	16.62	7.12	6.06	1.66	1.07	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	13.35	5.54	7.81	1.63	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	6.82	4.01	3.41	1.40	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	8.26	1.65	4.54	1.24	0.83	0.28
Olfactory epithelial cells, donor2	11934-125I8	9.41	3.33	4.20	1.88	0.72	0.14
Olfactory epithelial cells, donor3	11935-125I9	9.76	1.93	4.65	1.82	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	12.56	3.80	4.58	2.43	0.29	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	9.63	7.22	3.61	2.41	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	2.55	2.77	2.13	0.43	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	2.29	2.29	3.43	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	2.48	6.83	0.62	0.62	1.86
Osteoblast, donor1	11277-116H8	0.78	0.98	3.32	0.98	0.20	0.39
Osteoblast, donor2	11354-117H4	14.75	7.73	3.51	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	7.82	5.69	4.27	1.24	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	11.88	4.80	6.15	0.93	0.34	0.76
Pericytes, donor1	11491-119E6	2.11	1.45	0.89	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	2.49	1.36	1.36	0.45	0.45	0.23
Pericytes, donor3	11652-122E5	2.44	1.83	1.63	0.61	0.00	0.20
Perineurial Cells, donor1	11499-119F5	10.40	3.50	1.70	3.16	0.79	0.00
Perineurial Cells, donor2	11579-120F4	10.12	4.97	3.13	1.38	0.46	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	169.57	18.17	23.27	7.97	2.55	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	114.11	9.30	13.22	4.65	2.45	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	139.12	11.00	13.59	4.27	2.59	3.24
Placental Epithelial Cells, donor1	11278-116H9	3.59	3.35	7.41	1.20	0.00	0.96
Placental Epithelial Cells, donor2	11355-117H5	4.44	1.11	5.54	0.00	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	4.91	2.75	3.53	0.79	0.20	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.16	1.90	4.11	0.63	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	7.13	3.00	7.69	0.94	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.48	2.35	3.65	2.09	1.31	0.00
Preadipocyte - breast, donor2	11328-117E5	6.08	3.38	6.08	0.23	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	6.71	3.41	8.63	1.60	1.07	1.49
Preadipocyte - omental, donor2	11329-117E6	4.36	2.18	8.29	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	7.16	3.44	4.73	1.58	0.14	0.57
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.00	5.91	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.22	3.99	8.29	0.61	0.00	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	29.75	9.21	3.01	3.36	1.59	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	13.96	8.68	8.34	0.68	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	28.69	9.22	6.80	0.84	1.30	1.58
Preadipocyte - visceral, donor2	11357-117H7	25.31	9.66	12.89	2.76	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	20.69	7.11	2.93	2.40	0.84	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.14	9.50	3.17	2.56	1.36	0.60
Prostate Epithelial Cells, donor2	11331-117E8	8.80	1.22	1.35	0.81	0.14	0.41
Prostate Epithelial Cells, donor3	11404-118D9	6.55	4.16	1.71	2.82	0.92	0.31
Prostate Stromal Cells, donor1	11254-116F3	8.43	3.42	1.82	1.03	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	8.07	4.30	2.51	0.54	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	5.63	3.13	3.02	0.21	0.00	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.55	0.73	0.73	1.09	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.73	4.92	1.32	2.77	0.62	0.35
Renal Epithelial Cells, donor1	11517-119H5	1.52	0.51	1.52	0.51	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	1.42	0.71	0.71	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	14.61	5.29	2.75	1.80	0.42	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	0.00	1.36	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	2.56	1.75	0.94	1.75	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.54	5.77	2.44	3.11	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.00	0.00	2.00	1.33	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	2.42	1.54	1.98	0.44	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	1.25	1.88	1.25	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.83	0.83	0.83	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2.68	2.95	1.88	2.42	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1.27	3.80	1.27	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1.93	2.31	1.54	1.35	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.22	2.33	0.78	2.07	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	0.85	1.42	1.42	0.57	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	0.00	1.03	2.06	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	4.01	2.26	0.50	2.01	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.32	14.83	9.49	4.81	2.41	2.14
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	26.80	6.25	1.79	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	30.27	1.10	2.20	4.40	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.20	2.90	1.16	2.32	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.96	6.50	1.04	2.47	1.69	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.05	6.85	1.19	4.57	1.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	22.20	8.59	1.34	2.45	1.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	21.96	8.81	2.48	4.47	1.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	21.09	7.81	1.52	3.85	0.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.74	8.09	1.39	5.55	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.36	9.31	1.10	5.75	2.19	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	17.40	6.05	1.66	3.03	1.36	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	22.04	7.88	1.79	3.76	1.79	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	22.81	7.60	1.72	4.45	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.71	6.87	1.50	5.15	0.97	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	18.81	5.75	1.77	4.20	1.55	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.56	7.26	2.10	4.59	1.72	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	20.40	7.08	1.58	5.03	0.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.00	7.33	1.32	4.32	2.82	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.70	8.10	0.80	3.72	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.05	8.18	2.14	2.73	1.36	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.77	9.17	2.29	2.86	2.48	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	21.15	7.16	1.07	3.95	1.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.34	7.85	2.80	3.08	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.75	8.54	2.05	3.76	1.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.06	6.75	0.91	4.56	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.84	7.60	1.84	3.80	1.59	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.91	7.92	2.55	3.22	1.88	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.05	8.02	0.71	5.43	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	19.44	10.91	1.19	4.17	2.38	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	20.11	6.08	0.94	2.57	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.05	7.46	1.66	2.70	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	16.15	7.74	3.10	3.10	1.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	18.38	9.19	1.88	3.97	2.30	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	23.69	8.61	1.35	4.98	1.88	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	18.90	7.49	2.21	2.72	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	19.47	6.56	2.31	3.08	1.74	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.01	8.08	2.24	3.09	1.55	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.46	6.45	1.10	3.57	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	23.80	8.54	1.64	2.96	1.81	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.86	4.94	1.70	4.60	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.46	6.81	0.74	4.14	0.74	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.72	4.00	1.07	5.60	1.87	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.09	7.47	0.97	8.02	2.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.67	5.95	1.43	6.67	1.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.81	6.25	1.41	5.24	2.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.33	6.69	1.13	7.25	2.64	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.25	4.89	1.05	6.29	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.69	6.95	0.91	3.02	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.76	6.98	2.45	3.79	2.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	49.05	17.32	3.78	6.55	2.91	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	4.26	0.61	3.65	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	21.40	6.33	2.71	5.73	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	20.58	6.11	3.17	2.49	2.04	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	38.04	8.39	3.59	6.89	4.19	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	20.31	5.20	1.42	2.24	0.71	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.97	6.83	1.71	1.92	1.28	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	41.47	6.61	3.00	3.61	4.81	0.60
Schwann Cells, donor1	11498-119F4	3.57	1.88	1.69	1.69	0.19	0.00
Schwann Cells, donor2	11578-120F3	6.80	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.08	3.07	1.10	2.19	1.10	0.44
Sebocyte, donor1	11220-116B5	4.38	2.19	1.10	2.19	0.55	0.00
Sebocyte, donor2	11301-117B5	4.60	0.92	0.00	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	2.89	1.24	0.00	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	9.94	4.97	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	5.65	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	6.51	8.89	6.07	3.08	0.97	0.70
Skeletal Muscle Cells, donor2	11358-117H8	0.72	3.61	3.61	0.00	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	3.34	4.18	8.36	5.02	2.51	3.34
Skeletal Muscle Cells, donor4	11451-119A2	17.75	9.74	2.83	1.89	1.26	0.63
Skeletal Muscle Cells, donor5	11455-119A6	16.35	10.41	2.53	2.38	1.49	0.74
Skeletal Muscle Cells, donor6	11459-119B1	17.85	9.39	2.77	2.92	1.08	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	32.38	10.96	8.32	1.39	0.50	1.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.83	7.56	4.85	2.14	1.00	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	21.53	8.14	3.27	3.57	0.99	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.50	6.32	3.79	2.11	0.17	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	2.17	3.62	2.17	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.30	1.51	2.20	1.51	0.96	0.28
Skin - palm, donor1	10286-104F7	34.92	8.06	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.49	1.15	0.43	0.72	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	4.09	13.90	2.45	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.48	2.08	0.91	0.78	0.91	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	10.29	3.34	1.95	1.53	0.42	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	9.14	3.66	1.55	1.27	0.28	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.81	5.50	6.13	5.50	2.11	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	9.82	6.75	2.17	2.77	0.52	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.86	3.09	0.93	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.00	1.56	2.22	2.00	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.05	1.76	2.35	1.18	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.41	1.10	3.09	0.88	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	0.39	1.18	1.97	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7.73	3.86	6.18	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	5.00	2.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.26	1.73	2.00	0.67	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.98	2.66	5.32	0.89	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.45	2.82	1.41	1.54	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.81	4.23	1.95	1.95	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.97	4.43	1.77	0.59	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6.69	2.70	2.56	0.28	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.14	1.46	1.14	0.16	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.18	4.87	3.35	1.52	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3.28	3.28	7.83	0.76	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	6.12	6.12	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	0.95	3.34	0.95	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.00	3.98	2.06	0.44	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.90	4.09	3.01	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	8.19	5.35	2.62	1.36	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1.70	1.08	1.24	0.00	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	1.08	4.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	0.60	0.90	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.05	0.68	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	12.01	5.26	5.18	0.86	0.16	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.13	3.42	3.52	2.01	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	9.56	4.32	4.55	0.23	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	1.81	1.21	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.10	9.01	1.32	3.18	1.06	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.39	3.86	2.66	1.33	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	7.76	4.13	4.38	0.75	0.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.65	3.55	5.83	0.76	0.00	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	9.95	1.66	3.77	0.90	0.30	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	0.75	2.25	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	49.10	0.00	5.17	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	4.19	3.26	6.98	0.00	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.06	0.50	2.52	1.51	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.33	1.25	1.57	1.57	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.59	0.88	1.18	1.18	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	14.41	8.50	2.17	2.17	0.92	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	13.08	4.67	3.27	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1.15	1.15	1.01	0.43	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.43	2.29	1.02	1.27	1.02	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.63	1.69	1.88	0.94	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.69	6.29	1.12	1.96	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.04	3.85	1.51	0.59	0.25	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.95	0.00	0.95	0.00	0.00	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.18	0.98	1.96	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.84	3.98	1.77	1.33	0.88	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.70	4.10	2.05	1.46	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.16	3.69	6.80	0.58	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.23	2.12	1.06	1.32	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	1.12	2.23	0.37	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.55	3.95	2.87	0.36	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.52	2.56	1.70	0.28	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.09	2.76	1.58	0.39	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	2.54	3.30	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	2.80	5.59	1.20	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	5.85	2.93	2.93	0.84	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	8.25	4.58	6.88	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	6.23	4.88	3.87	0.84	1.18	1.01
Synoviocyte, donor2	11368-117I9	9.89	4.53	6.37	0.84	0.34	0.84
Synoviocyte, donor3	11440-118H9	8.04	4.47	6.26	1.12	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	3.22	1.07	2.14	0.00	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.47	3.01	3.24	0.46	0.46	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	7.10	2.58	1.00	1.94	0.36	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	0.77	1.55	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	1.15	0.57	1.72	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.30	15.50	9.84	5.04	2.83	1.60
Urethra, donor2	10319-105A4	41.36	21.58	5.40	3.60	1.80	1.80
Urothelial Cells, donor1	11520-119H8	1.06	0.27	0.27	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	0.00	0.80	0.00	0.00	0.80
Urothelial Cells, donor3	11681-122H7	2.98	1.15	0.23	0.69	0.00	0.00
Urothelial cells, donor0	11216-116B1	7.58	4.90	1.78	1.34	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	85.42	13.35	13.35	8.90	3.56	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	90.07	21.44	15.73	8.58	11.44	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	52.71	13.69	12.32	12.32	5.48	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	61.29	13.08	16.53	10.33	4.82	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	68.56	8.72	19.17	9.30	2.32	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	69.76	15.62	11.45	11.45	4.16	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	70.67	20.19	12.85	8.26	4.59	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	52.04	9.13	12.78	11.87	3.65	1.83
Wilms' tumor cell line:G-401	10809-111A8	24.67	4.69	1.11	3.58	0.99	0.12
Wilms' tumor cell line:HFWT	10597-108E3	7.04	4.40	1.76	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.85	5.03	1.40	6.42	0.84	0.56
achilles tendon, donor2	10292-104G4	68.20	8.27	2.07	4.13	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.16	7.39	1.27	13.00	1.78	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	23.91	9.29	3.71	13.00	4.18	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	71.94	15.67	5.94	8.43	1.54	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	33.20	8.44	1.90	4.90	2.18	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	29.51	5.06	3.37	1.97	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	34.26	6.13	5.08	3.81	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	37.29	4.90	5.17	6.81	2.18	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	37.45	7.93	12.78	4.85	1.32	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.36	4.49	5.72	5.31	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	52.81	6.99	8.93	2.72	1.55	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.67	3.86	2.02	6.44	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	15.60	11.70	0.00	7.80	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.88	5.11	5.11	2.32	1.63	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.42	6.73	7.77	3.37	2.59	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.37	6.14	11.11	7.01	2.05	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.03	5.11	8.37	2.79	2.79	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.10	3.29	7.40	8.23	2.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	21.79	7.67	3.38	1.53	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	27.74	6.83	5.55	3.84	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	25.17	10.92	6.07	3.03	1.52	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	30.09	9.87	5.05	4.09	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	18.26	8.46	4.23	4.90	2.90	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	14.01	5.00	4.00	3.34	1.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	37.16	24.16	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	27.12	7.91	3.01	1.13	1.88	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.07	4.80	4.80	3.93	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	15.00	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	15.54	7.30	2.35	6.83	2.59	0.00
adipose tissue, adult, pool1	10010-101C1	17.22	12.41	4.81	5.27	1.40	0.78
adipose, donor1	10184-103D4	59.23	8.21	4.10	3.52	0.00	0.59
adipose, donor2	10185-103D5	35.69	6.08	5.27	8.92	0.81	1.22
adipose, donor3	10186-103D6	34.58	8.17	5.99	4.63	2.45	1.36
adipose, donor4	10187-103D7	101.41	9.53	4.33	6.93	4.33	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.52	5.84	1.74	7.10	2.68	0.16
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.35	8.14	2.67	7.74	1.33	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	51.81	6.43	7.50	2.86	1.07	1.79
amniotic membrane cells, donor1	12235-129G3	18.55	13.45	3.48	2.09	1.39	1.62
amniotic membrane cells, donor2	12236-129G4	35.50	11.83	12.51	2.37	3.72	3.72
amniotic membrane cells, donor3	12237-129G5	13.55	10.31	1.47	0.59	0.88	0.29
amygdala - adult, donor10196	10167-103B5	9.49	1.19	0.00	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	11.76	6.49	4.66	5.07	3.65	1.22
amygdala, newborn, donor10223	10360-105E9	13.23	2.58	3.87	6.46	0.97	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	11.33	8.40	4.33	2.42	0.76	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	36.18	8.82	1.32	2.65	3.75	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.74	8.02	2.67	5.68	3.34	0.67
aorta, adult, pool1	10052-101G7	15.69	7.26	4.71	3.33	1.37	0.20
appendix, adult	10189-103D9	35.71	15.91	8.15	10.48	3.88	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	5.50	1.38	7.57	8.25	2.06	0.69
artery, adult	10190-103E1	4.08	8.15	4.08	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	18.98	8.84	7.68	3.77	0.87	1.01
b cell line:RPMI1788	10427-106D4	21.56	5.65	0.89	8.48	1.78	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.10	1.94	2.22	0.83	0.83	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	15.48	8.34	2.48	2.58	0.79	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	20.09	10.21	2.01	5.36	0.84	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.25	2.80	2.80	1.12	1.12	1.12
bladder, adult, pool1	10011-101C2	17.60	14.56	3.04	2.82	1.41	0.11
blood, adult, pool1	10053-101G8	59.79	11.07	11.07	6.64	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	6.85	5.99	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	18.22	12.82	8.10	5.40	1.35	1.35
brain, adult, donor1	10084-102B3	7.18	4.10	4.10	8.20	1.03	0.00
brain, adult, pool1	10012-101C3	10.02	4.34	2.67	5.23	1.45	0.45
brain, fetal, pool1	10085-102B4	18.70	2.67	2.67	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	26.76	6.28	4.63	2.97	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	36.57	13.11	5.37	7.36	2.50	1.75
breast, adult, donor1	10080-102A8	20.20	8.84	3.16	7.58	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	19.69	2.67	1.91	1.27	0.76	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	35.56	10.20	5.88	5.57	3.71	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.51	3.22	1.38	4.37	1.38	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.52	7.50	2.42	4.36	0.73	1.21
carcinoid cell line:NCI-H1770	10703-109H1	4.23	12.22	1.41	7.99	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.22	8.53	4.70	3.17	0.98	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	22.82	10.14	1.58	6.97	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	44.45	18.37	9.05	2.40	1.60	2.93
caudate nucleus - adult, donor10196	10177-103C6	18.42	6.91	1.15	9.21	3.45	2.30
caudate nucleus, adult, donor10252	10164-103B2	9.70	5.02	9.87	6.86	2.68	0.84
caudate nucleus, adult, donor10258	10379-105H1	8.41	4.58	5.35	5.35	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	10.99	5.49	4.03	6.59	2.93	1.10
cerebellum - adult, donor10196	10173-103C2	14.57	2.91	0.00	55.35	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	12.81	9.61	5.76	52.52	10.68	0.64
cerebellum, adult, pool1	10083-102B2	6.90	2.76	2.41	25.18	4.48	0.34
cerebellum, newborn, donor10223	10357-105E6	14.11	4.15	1.66	20.76	8.30	0.83
cerebral meninges, adult	10188-103D8	9.08	3.53	3.03	1.51	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	12.43	5.85	2.92	2.19	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.95	4.17	0.58	3.16	1.29	0.14
cervical cancer cell line:ME-180	10553-107I4	16.57	4.64	2.32	2.49	2.15	0.66
cervix, adult, pool1	10013-101C4	29.71	19.84	7.77	5.04	2.52	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.96	5.57	5.29	0.98	0.70	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	5.23	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	30.94	15.78	3.11	9.32	2.24	0.50
choriocarcinoma cell line:SCH	10785-110H2	15.77	9.86	2.09	2.09	0.62	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	21.58	18.97	2.37	5.46	0.71	0.47
chorionic membrane cells, donor1	12238-129G6	13.96	8.83	5.13	3.13	0.85	1.42
chorionic membrane cells, donor2	12239-129G7	14.52	6.46	4.18	1.59	1.39	0.70
chorionic membrane cells, donor3	12240-129G8	20.33	15.94	2.75	4.95	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	1.01	5.05	2.02	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	23.24	2.69	2.31	2.11	1.73	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.50	4.01	2.75	2.75	1.69	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	21.83	7.70	4.11	9.24	1.28	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.87	4.60	5.81	12.09	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.73	8.14	4.28	12.42	2.24	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	27.68	9.42	5.59	10.31	1.77	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	34.14	8.86	0.78	3.13	1.30	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.49	2.74	1.60	2.74	2.74	0.00
clear cell carcinoma cell line:TEN	10636-108I6	12.15	3.99	1.39	2.26	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	30.38	10.80	4.58	3.48	0.55	0.73
colon carcinoma cell line:COLO-320	10420-106C6	12.54	6.08	2.66	25.09	1.52	0.38
colon, adult, donor1	10082-102B1	23.80	11.90	2.38	2.38	1.19	0.00
colon, adult, pool1	10014-101C5	20.33	16.33	4.94	4.94	1.88	0.24
colon, fetal, donor1	10070-101I7	45.11	9.89	2.47	6.18	3.71	0.62
common myeloid progenitor CMP, donor1	12130-128D6	165.01	13.75	36.67	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.50	9.35	2.12	14.87	3.40	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.72	4.98	2.11	6.94	2.26	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	13.68	6.20	1.27	8.88	1.83	0.00
corpus callosum, adult, pool1	10042-101F6	11.06	5.75	3.32	6.08	2.32	0.55
cruciate ligament, donor2	10295-104G7	37.28	12.16	8.10	3.24	4.86	1.62
diaphragm, fetal, donor1	10069-101I6	23.27	8.03	3.21	5.62	2.41	0.00
diencephalon, adult	10193-103E4	8.40	2.88	3.60	1.68	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.29	4.59	4.59	7.12	2.53	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	19.49	6.92	4.62	2.82	0.51	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.76	5.78	1.93	0.96	0.00	0.24
ductus deferens, adult	10196-103E7	19.44	8.97	5.48	2.99	2.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	10.08	4.32	10.08	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	31.63	15.45	4.41	3.68	2.21	0.74
dura mater, adult, donor1	10041-101F5	30.72	11.81	13.30	1.73	0.58	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	23.98	7.77	5.55	6.66	2.89	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	14.76	6.73	1.43	4.30	1.15	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	9.25	3.08	3.08	2.47	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	6.96	4.84	1.21	1.82	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.42	9.26	3.40	3.70	0.31	1.23
embryonic pancreas cell line:2C6	10603-108E9	15.76	9.19	2.63	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.10	6.37	4.36	1.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	12.32	5.26	5.98	13.23	3.62	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	8.20	3.70	1.77	0.96	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	18.45	5.56	2.67	1.00	1.33	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.26	7.70	1.65	3.30	2.20	0.55
epididymis, adult	10197-103E8	20.93	10.05	10.47	3.35	2.09	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.68	5.85	6.03	2.31	1.06	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.65	1.18	0.79	1.57	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.66	4.59	1.83	4.46	1.31	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.72	3.94	2.07	6.79	2.36	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	13.78	5.71	1.57	5.27	1.79	0.11
esophagus, adult, pool1	10015-101C6	17.94	8.39	2.23	3.29	1.17	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	44.33	8.64	8.39	4.01	1.00	0.63
eye - muscle inferior rectus, donor1	10272-104E2	26.56	2.41	7.24	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	0.00	4.21	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	10.42	2.98	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	2.29	1.15	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	1.46	0.00	5.83	2.91	0.00
eye, fetal, donor1	10054-101G9	13.73	6.61	2.03	9.15	2.03	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	12.95	3.46	3.46	2.44	0.64	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	20.66	5.70	2.14	4.51	1.19	0.47
frontal lobe, adult, pool1	10040-101F4	8.73	3.66	5.44	5.63	1.78	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	18.92	9.31	3.30	2.40	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.70	3.20	0.91	1.19	0.46	0.18
gall bladder, adult	10198-103E9	15.69	7.24	5.31	1.93	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	79.99	8.59	16.11	8.05	2.68	1.07
gamma delta positive T cells, donor2	11938-126A3	93.75	6.72	16.81	5.98	3.36	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	11.83	1.48	4.22	2.53	0.84	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.63	11.02	2.71	1.16	1.16	0.19
gastric cancer cell line:AZ521	10549-107H9	40.82	6.07	3.93	9.18	3.12	0.33
gastric cancer cell line:GSS	10560-108A2	23.80	5.49	0.00	9.15	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	27.64	6.85	3.66	3.20	2.74	0.69
giant cell carcinoma cell line:LU65	10487-107B1	4.47	4.25	0.92	3.90	0.46	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	27.57	5.60	3.78	1.68	0.98	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.45	6.73	0.25	4.24	2.24	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.36	5.81	3.91	2.96	0.84	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	13.48	5.76	2.95	2.81	0.98	0.14
glioblastoma cell line:T98G	10485-107A8	45.92	10.60	9.60	3.20	0.88	1.10
glioma cell line:GI-1	10413-106B8	14.35	4.39	2.93	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	18.95	2.19	0.00	2.92	4.37	0.73
globus pallidus, adult, donor10252	10161-103A8	21.24	8.54	6.59	4.15	3.42	0.98
globus pallidus, adult, donor10258	10367-105F7	19.17	4.11	5.48	1.37	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	6.93	2.13	4.26	3.20	1.07	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	149.28	51.39	24.47	0.00	2.45	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.84	2.24	4.16	0.96	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	24.79	1.84	0.92	7.80	5.05	0.00
hIPS +CCl2, biol_rep2	14384-156C1	18.29	5.03	2.74	3.20	2.29	0.91
hIPS +CCl2, biol_rep3	14385-156C2	19.97	1.29	1.29	9.66	3.22	0.00
hIPS, biol_rep1	14380-156B6	33.06	2.87	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	27.43	5.49	2.06	1.37	5.49	0.69
hIPS, biol_rep3	14382-156B8	8.83	7.72	0.00	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	23.56	2.59	0.29	5.75	3.45	0.00
heart - mitral valve, adult	10205-103F7	13.75	7.18	1.79	2.09	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	15.95	7.84	2.35	1.83	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	14.15	19.15	5.00	5.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	10.00	2.86	2.04	1.84	0.82	0.41
heart, adult, diseased, donor1	10051-101G6	4.68	2.98	0.43	1.70	0.43	0.00
heart, adult, pool1	10016-101C7	7.82	6.67	1.15	2.07	3.22	0.23
heart, fetal, pool1	10046-101G1	15.92	8.93	3.49	8.21	3.70	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.87	2.47	3.70	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	23.78	21.41	8.32	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	33.92	11.60	5.41	7.18	2.76	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	34.83	12.99	5.34	4.73	2.67	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	37.19	13.24	6.87	5.86	2.93	1.21
hepatoma cell line:Li-7	10484-107A7	12.01	4.45	2.11	1.45	0.33	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.20	3.52	1.51	4.02	0.90	0.20
hippocampus - adult, donor10196	10169-103B7	7.57	0.95	4.73	4.73	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	14.49	4.29	7.96	7.14	2.25	0.61
hippocampus, adult, donor10258	10374-105G5	8.47	2.99	5.98	1.99	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	8.81	2.47	4.23	3.52	3.52	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	20.14	5.49	1.83	3.05	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.26	8.84	0.39	9.03	2.95	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	15.74	8.38	1.02	8.38	3.81	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.99	10.15	5.64	19.74	2.26	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	25.82	13.69	8.00	20.40	1.81	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.61	14.05	12.15	16.32	1.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.12	12.26	7.01	4.96	1.75	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	27.57	10.77	7.54	7.32	1.94	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.53	15.43	7.51	6.26	1.25	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.34	10.66	4.74	5.45	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	17.52	9.80	4.18	8.84	1.77	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	25.59	10.77	6.06	4.04	0.67	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.24	7.67	0.78	6.26	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.26	5.40	0.98	5.90	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	15.71	5.24	0.87	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.31	10.50	8.21	22.15	2.48	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.71	8.72	8.72	17.01	1.31	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	41.98	8.00	7.00	6.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	23.55	8.67	7.35	8.85	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	26.37	11.82	3.64	11.37	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.00	11.28	6.26	7.52	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.53	5.72	3.76	7.51	1.14	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.39	4.35	4.35	5.23	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.64	2.39	4.78	6.28	2.09	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.52	9.61	1.48	8.68	1.85	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	18.26	9.13	1.43	5.14	1.43	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	25.32	6.12	1.63	3.67	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.39	7.39	5.63	7.75	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	31.04	11.72	8.55	6.02	0.95	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.56	12.41	8.17	9.99	2.72	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.41	7.76	8.27	4.14	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.92	7.31	3.98	3.98	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.17	8.47	6.16	4.62	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.85	5.62	6.14	2.30	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.20	7.57	7.57	3.79	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.19	4.70	5.04	3.70	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	17.39	8.45	1.69	8.45	2.90	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	12.03	10.70	1.34	6.68	3.12	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	19.02	6.83	0.98	8.29	3.41	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	24.76	12.84	5.81	12.53	1.22	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	13.01	3.25	9.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.07	8.94	6.95	6.29	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.44	9.30	8.21	4.93	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.35	13.03	5.79	5.07	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	23.13	7.47	7.12	7.12	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	1.19	5.97	3.58	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.82	10.16	5.42	6.91	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.36	5.39	4.31	7.00	1.08	0.27
immature langerhans cells, donor1	11904-125F5	45.77	5.09	2.66	0.97	0.24	0.48
immature langerhans cells, donor2	11905-125F6	37.23	5.54	3.17	2.38	1.58	0.00
insula, adult, pool1	10039-101F3	8.80	3.60	5.11	6.34	1.23	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	14.63	0.98	4.88	5.53	1.30	1.30
kidney, adult, pool1	10017-101C8	16.42	8.11	6.31	5.11	1.60	0.30
kidney, fetal, pool1	10045-101F9	14.43	6.65	5.31	7.50	2.33	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	11.65	7.24	3.83	1.85	1.14	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.23	2.63	1.80	3.46	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.40	10.46	1.83	3.12	0.73	1.10
left atrium, adult, donor1	10079-102A7	11.44	5.99	1.09	2.18	1.63	0.54
left ventricle, adult, donor1	10078-102A6	9.61	2.53	1.52	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	24.35	8.76	1.92	6.02	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	3.23	1.44	4.67	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	3.80	2.72	1.63	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	7.28	1.21	0.49	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	0.00	3.14	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.32	6.38	1.53	4.01	0.83	0.24
liposarcoma cell line:KMLS-1	10782-110G8	19.06	5.31	8.44	1.56	0.00	0.78
liposarcoma cell line:SW 872	10726-110A6	10.60	4.63	6.34	1.83	0.97	0.61
liver, adult, pool1	10018-101C9	9.89	4.21	4.54	2.76	1.94	0.49
liver, fetal, pool1	10086-102B5	4.70	9.41	0.94	5.64	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	11.81	6.27	1.02	5.83	3.21	0.15
locus coeruleus, adult, donor10252	10165-103B3	11.81	6.83	2.40	4.06	2.03	0.37
locus coeruleus, adult, donor10258	10375-105G6	7.05	2.54	1.13	1.69	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	4.63	3.79	2.10	5.89	2.10	0.00
lung adenocarcinoma cell line:A549	10499-107C4	9.55	3.60	2.91	2.63	0.14	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	6.20	4.14	11.72	0.69	0.69	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.45	4.88	7.25	1.85	1.19	0.26
lung, adult, pool1	10019-101D1	24.45	10.28	4.84	5.32	1.42	0.71
lung, fetal, donor1	10068-101I5	40.53	19.98	7.14	10.27	5.42	2.28
lung, right lower lobe, adult, donor1	10075-102A3	20.16	6.87	5.50	5.96	3.67	0.00
lymph node, adult, donor1	10077-102A5	35.03	7.10	6.63	11.83	3.79	0.47
lymphangiectasia cell line:DS-1	10727-110A7	39.89	8.11	4.82	1.75	0.66	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	23.70	6.94	4.38	12.68	2.57	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.13	7.65	0.85	0.85	1.70	1.70
mature adipocyte, donor1	12231-129F8	11.10	6.22	2.22	1.78	0.00	0.44
mature adipocyte, donor2	12232-129F9	9.96	6.43	2.70	3.11	0.00	0.21
mature adipocyte, donor3	12233-129G1	8.53	7.35	1.42	1.19	0.24	0.95
mature adipocyte, donor4	12234-129G2	15.27	8.42	2.37	1.58	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	20.73	6.19	3.57	4.53	0.95	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	2.26	5.64	5.64	4.51	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	6.99	5.70	5.52	7.91	4.97	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	1.27	3.81	1.27	1.27	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	5.54	0.43	2.13	1.71	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	9.11	2.03	3.04	7.09	1.86	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	14.43	5.94	6.37	9.34	3.82	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	0.00	5.78	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.97	1.08	4.31	3.95	1.79	0.72
medulla oblongata - adult, donor10196	10174-103C3	20.77	1.95	1.30	5.84	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	13.00	7.43	5.73	7.89	3.41	1.08
medulla oblongata, adult, pool1	10038-101F2	9.14	5.55	2.78	3.10	1.31	0.57
medulla oblongata, newborn, donor10223	10361-105F1	11.11	4.86	2.43	5.90	1.74	2.08
medulloblastoma cell line:D283 Med	10838-111E1	46.50	18.16	7.09	4.21	4.21	0.22
medulloblastoma cell line:ONS-76	10759-110E3	16.14	3.55	0.98	3.06	0.86	0.00
melanoma cell line:COLO 679	10514-107E1	11.79	5.75	1.87	2.30	0.86	0.72
melanoma cell line:G-361	10465-106H6	9.50	1.36	1.09	4.34	0.27	0.54
meningioma cell line:HKBMM	10691-109F7	8.50	3.44	0.72	1.81	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.89	9.69	7.93	11.46	7.05	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	30.85	9.07	5.18	10.11	5.70	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.72	7.36	4.60	1.23	0.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.36	7.09	3.27	1.27	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	3.31	4.56	0.83	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.50	4.07	1.40	1.83	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.20	4.62	4.04	1.16	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	5.55	2.78	2.78	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.49	3.78	3.09	1.20	0.69	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.21	3.80	1.27	0.81	0.23	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.41	3.85	3.98	0.66	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.59	3.78	2.97	0.95	0.27	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	10.53	5.12	2.99	1.42	0.71	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.29	6.26	4.61	2.31	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.65	5.53	4.57	1.80	0.97	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.12	2.44	5.59	1.75	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.72	1.43	1.43	1.63	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.59	3.59	1.44	0.36	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.21	3.10	1.97	0.72	0.52	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.02	0.68	1.60	0.46	0.46	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.75	5.03	2.10	1.26	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.47	2.24	3.44	1.20	0.75	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.27	4.38	3.76	0.88	0.26	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.79	3.68	5.52	0.74	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	5.72	2.58	2.00	0.57	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	11.37	5.47	2.95	1.26	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.39	3.20	6.39	1.83	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	3.58	4.35	1.02	1.02	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.99	4.19	4.71	0.79	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.63	5.85	3.70	1.23	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.77	2.82	4.94	0.47	1.41	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.48	3.72	5.75	1.02	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	10.22	5.11	8.25	1.18	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	2.78	3.71	1.39	0.00	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.00	5.77	5.77	1.44	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.60	5.58	5.80	0.67	1.56	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.65	4.81	5.29	0.96	0.48	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	5.87	2.93	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.75	4.03	5.37	1.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.55	4.50	5.32	1.64	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.73	5.58	3.87	1.29	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	15.49	5.16	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	2.92	5.52	1.30	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	5.82	2.91	1.45	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	8.00	6.40	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	15.54	3.27	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	5.83	4.28	1.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	4.20	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	5.96	4.97	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	4.74	4.74	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	3.66	8.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	5.07	3.80	0.63	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.42	2.76	6.55	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	4.30	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	3.99	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	4.48	7.33	0.41	0.00	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	3.18	9.53	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	4.13	9.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.29	4.36	4.36	1.25	0.31	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	2.67	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	0.00	2.37	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	5.51	3.44	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	5.94	3.46	0.49	0.00	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	1.12	5.61	2.24	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.09	2.54	3.18	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.03	2.82	4.84	1.61	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	0.00	4.36	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	1.27	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	3.03	1.21	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	1.65	4.12	1.65	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.91	3.37	2.78	0.99	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.01	4.54	3.89	1.30	0.97	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	6.11	2.04	0.00	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.15	3.87	3.09	1.55	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.14	8.50	4.72	4.02	0.94	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.19	6.72	7.65	1.39	0.70	3.01
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.42	1.95	2.06	0.41	0.62	0.21
mesothelioma cell line:Mero-25	10850-111F4	7.72	2.95	0.68	1.36	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	14.91	6.36	3.42	1.71	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	12.62	4.43	3.76	1.77	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	24.18	6.04	3.42	2.63	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	15.83	3.06	2.55	0.85	1.02	0.17
mesothelioma cell line:Mero-84	10855-111F9	10.36	2.27	4.30	0.51	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	12.42	4.76	5.38	1.04	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	16.07	4.80	1.33	0.99	1.49	0.83
mesothelioma cell line:NCI-H226	10846-111E9	21.90	2.17	1.99	0.72	0.00	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	19.47	4.10	9.91	2.05	0.68	0.51
mesothelioma cell line:NCI-H28	10845-111E8	22.90	7.38	6.87	4.33	1.78	2.04
mesothelioma cell line:No36	10857-111G2	9.13	4.57	1.96	1.63	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	15.17	3.52	3.79	0.54	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	17.66	3.65	0.77	2.11	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	14.78	4.64	0.85	2.32	0.61	0.00
migratory langerhans cells, donor3	11903-125F4	13.46	6.28	0.72	1.97	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.53	3.26	0.65	2.61	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.72	0.85	0.42	0.64	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	21.88	7.14	2.53	0.69	0.69	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.75	2.28	2.85	5.52	0.38	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	14.97	7.95	4.25	6.47	1.48	0.55
myeloma cell line:PCM6	10474-106I6	20.76	3.95	3.56	4.94	2.37	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	13.19	2.54	3.55	1.52	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.32	3.14	5.30	2.75	1.18	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.46	4.90	0.67	3.90	0.78	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.32	4.85	0.74	1.99	0.22	0.15
nasal epithelial cells, donor2	12227-129F4	28.70	4.97	3.86	2.76	3.86	0.00
neuroblastoma cell line:CHP-134	10508-107D4	24.39	11.73	2.53	8.97	3.45	0.69
neuroblastoma cell line:NB-1	10539-107G8	16.65	9.54	3.37	8.61	5.05	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	9.70	4.01	1.27	6.54	0.63	1.05
neuroblastoma cell line:NH-12	10555-107I6	28.51	9.50	4.66	11.55	2.98	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.23	8.78	3.08	7.59	1.42	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	22.01	7.92	6.18	5.07	1.27	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	18.92	5.23	2.01	2.62	0.60	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.17	11.44	1.91	4.45	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	13.31	4.26	2.66	1.60	0.00	0.53
neutrophil PMN, donor1	12133-128D9	193.37	59.50	14.87	14.87	0.00	14.87
neutrophil PMN, donor2	12137-128E4	146.09	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	37.88	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	99.10	17.76	16.57	47.35	11.84	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	21.61	5.60	4.80	0.00	0.00	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.09	2.89	3.85	0.00	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	10.25	6.04	2.36	0.79	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	8.62	4.12	5.72	6.00	1.59	0.28
occipital cortex - adult, donor10196	10172-103C1	8.24	0.00	2.06	4.12	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	13.15	5.37	6.44	9.12	4.03	0.27
occipital cortex, newborn, donor10223	10355-105E4	7.64	4.00	4.73	4.37	3.28	0.00
occipital lobe, adult, donor1	10076-102A4	8.66	2.62	2.89	4.20	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	16.73	9.87	3.00	19.31	6.01	0.86
occipital pole, adult, pool1	10036-101E9	3.94	2.21	3.23	3.47	0.87	0.39
olfactory region, adult	10195-103E6	9.17	4.59	4.01	5.16	1.53	0.57
optic nerve, donor1	10277-104E7	14.01	6.00	6.00	6.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.74	6.49	3.76	5.13	0.91	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.84	3.98	0.41	7.69	1.37	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.76	2.71	1.86	1.02	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	18.48	7.28	2.66	3.93	2.08	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	11.76	4.12	5.00	2.06	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	10.28	10.28	3.74	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	11.66	5.94	2.12	2.33	0.64	0.64
ovary, adult, pool1	10020-101D2	12.32	15.64	5.15	4.89	1.57	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.62	2.75	1.65	1.47	0.73	0.55
pancreas, adult, donor1	10049-101G4	13.17	4.70	2.82	3.76	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	25.16	11.18	2.24	5.31	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	7.84	4.43	1.36	1.53	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	15.90	8.11	4.14	2.98	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	6.86	4.21	4.12	5.31	0.82	0.55
parietal cortex, adult, donor10258	10373-105G4	14.68	2.20	4.40	3.67	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	7.52	0.00	0.94	8.46	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	9.98	5.42	6.27	8.55	5.13	0.57
parietal lobe, adult, pool1	10034-101E7	5.73	2.64	4.49	4.58	1.59	0.35
parietal lobe, fetal, donor1	10072-101I9	20.37	13.58	2.91	28.13	7.76	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.96	2.62	4.49	4.49	2.62	0.75
parotid gland, adult	10199-103F1	9.87	6.17	3.08	3.70	2.47	0.00
penis, adult	10200-103F2	17.19	12.89	4.83	1.61	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.87	15.43	1.86	4.09	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.56	3.64	6.70	2.19	1.17	0.44
pineal gland - adult, donor10196	10179-103C8	19.35	4.52	2.58	1.94	4.52	0.00
pineal gland, adult, donor10252	10160-103A7	12.44	4.15	7.70	8.88	3.55	0.59
pineal gland, adult, donor10258	10377-105G8	18.19	5.02	5.64	4.39	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	16.19	10.12	7.08	7.08	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	36.48	8.86	11.99	13.03	9.90	1.04
pituitary gland, adult, donor10258	10378-105G9	17.02	5.11	5.96	6.81	2.55	0.00
placenta, adult, pool1	10021-101D3	23.97	17.52	4.09	3.33	1.83	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	17.61	4.24	1.99	9.14	2.12	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.66	4.98	2.18	1.87	0.93	0.16
pons, adult, pool1	10033-101E6	8.78	3.96	2.32	5.34	1.46	0.17
postcentral gyrus, adult, pool1	10032-101E5	4.71	2.79	4.18	4.27	0.52	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	94.11	20.91	18.82	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	16.02	3.50	0.73	4.52	1.60	0.15
prostate cancer cell line:PC-3	10439-106E7	19.97	7.08	4.17	3.63	1.09	1.09
prostate, adult, pool1	10022-101D4	21.22	10.61	6.62	3.08	2.00	0.63
putamen, adult, donor10196	10176-103C5	10.62	4.96	3.07	7.55	3.30	0.00
putamen, adult, donor10252	10152-102I8	7.84	9.80	3.92	3.92	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	7.65	2.19	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.97	2.66	3.62	7.73	2.90	0.00
putamen, newborn, donor10223	10365-105F5	9.00	1.50	2.25	6.75	4.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	13.96	12.51	1.75	1.75	0.58	0.29
rectum, fetal, donor1	10067-101I4	52.86	27.82	1.39	5.56	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.55	3.18	10.18	1.70	1.48	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.57	6.21	4.97	1.66	0.41	0.00
retina, adult, pool1	10030-101E3	14.41	4.27	7.75	5.27	1.69	0.80
retinoblastoma cell line:Y79	10475-106I7	22.08	11.69	4.94	12.47	2.60	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.56	4.92	1.11	2.70	1.11	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	51.46	28.68	10.69	2.53	0.56	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	5.30	4.55	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	15.70	1.29	4.05	0.65	0.49	0.00
salivary acinar cells, donor2	11772-123I8	19.55	3.58	3.99	0.69	0.55	0.28
salivary acinar cells, donor3	11773-123I9	15.89	5.30	4.63	0.00	1.99	0.00
salivary gland, adult, pool1	10093-102C3	11.44	8.01	1.72	3.43	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	5.14	2.78	1.10	1.85	0.59	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	3.88	2.94	1.06	2.12	0.47	0.24
seminal vesicle, adult	10201-103F3	25.40	6.35	8.99	4.23	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.51	8.26	13.60	0.97	0.73	5.59
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.79	3.77	2.26	1.26	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	20.07	8.03	1.00	4.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.91	8.19	1.21	3.09	1.48	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	21.11	5.97	1.88	4.86	1.11	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.32	5.55	4.77	2.97	1.81	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	8.51	4.97	1.42	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	7.32	6.48	1.32	5.40	1.92	0.24
skeletal muscle, fetal, donor1	10066-101I3	9.05	3.02	3.02	7.04	2.01	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	6.79	20.36	0.00	0.00
skin, fetal, donor1	10065-101I2	47.34	12.62	3.79	7.57	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	19.68	11.34	6.00	7.00	4.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	85.11	18.60	11.98	3.47	5.04	6.62
small cell lung carcinoma cell line:DMS 144	10841-111E4	11.56	5.20	5.20	7.52	2.89	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	26.70	8.90	2.97	13.85	2.64	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	17.85	13.35	2.25	13.67	3.86	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.45	10.90	7.19	6.54	1.31	2.40
small intestine, adult, pool1	10024-101D6	25.32	11.94	4.66	7.64	1.91	0.48
small intestine, fetal, donor1	10064-101I1	22.36	6.88	4.18	4.42	2.21	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	19.49	7.18	1.03	1.54	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	14.22	7.50	2.84	2.58	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	22.78	4.29	2.14	1.61	1.07	0.00
spinal cord - adult, donor10196	10181-103D1	16.75	5.51	1.15	8.26	2.06	0.00
spinal cord, adult, donor10252	10159-103A6	18.92	5.13	5.91	7.10	3.94	0.79
spinal cord, adult, donor10258	10369-105F9	15.22	1.38	1.38	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	12.20	9.15	3.66	8.54	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	10.56	3.21	0.92	2.76	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.25	4.03	1.94	1.79	0.30	0.45
spleen, adult, pool1	10025-101D7	23.46	8.37	7.16	9.36	3.52	0.66
spleen, fetal, pool1	10044-101F8	20.50	9.77	6.04	8.74	1.99	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.49	3.73	4.04	6.52	1.35	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.52	7.22	2.47	2.09	1.90	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.28	4.19	0.70	1.75	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	3.91	1.17	0.39	1.17	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.99	3.15	0.68	5.29	1.80	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.99	2.97	2.97	4.24	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	22.00	11.00	2.96	1.69	1.27	0.00
stomach, fetal, donor1	10062-101H8	28.84	11.75	5.34	2.14	1.07	1.07
submaxillary gland, adult	10202-103F4	23.93	9.11	1.71	2.28	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	16.82	8.72	4.57	4.78	2.28	1.04
substantia nigra, adult, donor10258	10371-105G2	10.35	1.03	2.59	2.07	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	14.84	4.95	3.53	2.83	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	25.91	4.59	3.90	3.90	1.60	0.69
temporal lobe, adult, pool1	10031-101E4	4.58	1.70	4.24	4.58	0.59	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.83	9.97	4.27	10.68	3.56	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	5.27	7.91	8.35	3.96	1.32
tenocyte, donor1	11763-123H8	11.52	9.08	7.68	3.49	1.05	0.35
tenocyte, donor2	11765-123I1	6.49	1.91	9.92	1.91	2.67	0.38
tenocyte, donor3	11768-123I4	8.15	7.41	1.11	1.48	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	43.51	9.52	2.21	11.39	1.53	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	33.60	10.17	4.47	2.93	1.54	0.92
teratocarcinoma cell line:PA-1	10807-111A6	20.61	8.83	1.24	10.07	1.55	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	5.59	4.70	1.14	3.17	1.40	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.29	10.97	3.03	14.37	4.92	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.54	8.94	1.20	1.96	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4.89	3.91	0.98	6.51	3.26	0.33
testis, adult, pool1	10026-101D8	12.56	11.92	6.66	8.59	3.11	0.32
testis, adult, pool2	10096-102C6	8.57	4.96	6.32	13.53	3.16	1.35
thalamus - adult, donor10196	10168-103B6	15.46	7.73	2.21	8.83	0.00	0.00
thalamus, adult, donor10252	10154-103A1	16.88	7.03	7.19	6.56	3.13	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	1.54	6.16	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.89	2.64	1.48	3.95	1.15	0.49
thalamus, newborn, donor10223	10366-105F6	9.21	0.58	2.30	3.45	2.88	0.00
throat, adult	10209-103G2	17.73	7.74	5.24	3.99	2.25	0.50
throat, fetal, donor1	10061-101H7	42.05	10.97	7.62	6.70	2.44	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	27.42	10.14	3.97	10.14	1.39	0.60
thymus, adult, pool1	10027-101D9	74.16	25.15	7.26	34.30	5.27	0.60
thymus, fetal, pool1	10043-101F7	78.66	21.30	8.00	31.90	4.88	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	16.49	5.72	2.93	2.13	1.06	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	11.45	6.84	1.82	3.91	0.56	0.70
thyroid, adult, pool1	10028-101E1	18.94	10.36	21.84	8.30	1.59	5.51
thyroid, fetal, donor1	10060-101H6	29.27	8.96	6.33	8.17	5.01	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	6.16	12.32	3.08	0.00	0.00
tongue, adult	10203-103F5	13.95	7.21	2.79	3.02	0.70	0.47
tongue, fetal, donor1	10059-101H5	18.92	6.31	1.97	4.34	1.58	0.79
tonsil, adult, pool1	10047-101G2	29.45	9.92	5.41	7.71	2.60	0.40
trachea, adult, pool1	10029-101E2	15.79	8.34	6.30	3.27	1.72	0.90
trachea, fetal, donor1	10058-101H4	23.47	9.23	2.69	4.62	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.75	2.83	1.77	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	22.80	7.90	5.37	2.74	0.81	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	21.47	15.51	3.45	5.33	0.63	0.94
tridermal teratoma cell line:HGRT	10694-109G1	19.03	11.42	5.71	0.00	0.00	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.66	5.33	5.42	1.27	0.68	1.02
umbilical cord, fetal, donor1	10057-101H3	20.87	10.43	0.00	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	18.26	12.46	6.83	4.27	2.05	0.34
uterus, fetal, donor1	10055-101H1	59.38	11.26	4.10	2.56	2.56	1.02
vagina, adult	10204-103F6	10.99	12.92	5.82	9.05	2.58	0.65
vein, adult	10191-103E2	30.47	7.01	5.92	8.77	4.16	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.22	3.20	4.27	4.27	1.07	0.00